Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Clinical trial NCT00376064 · COMPLETED
Trial details
- NCT number
- NCT00376064
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2010-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.